Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability

被引:50
作者
Blana, Andreas [1 ]
Kaese, Sven [1 ]
Fortmueller, Lisa [1 ,2 ]
Laakmann, Sandra [1 ,2 ]
Damke, Dierk [1 ]
van Bragt, Kelly [3 ]
Eckstein, Jens [3 ]
Piccini, Ilaria [1 ]
Kirchhefer, Uwe [2 ,4 ]
Nattel, Stanley [5 ,6 ]
Breithardt, Guenter [1 ]
Carmeliet, Peter [7 ]
Carmeliet, Edward [7 ]
Schotten, Ulrich [3 ]
Verheule, Sander [3 ]
Kirchhof, Paulus [1 ,2 ]
Fabritz, Larissa [1 ,2 ]
机构
[1] Univ Hosp Munster, Dept Cardiol & Angiol, D-48129 Munster, Germany
[2] Interdisciplinary Ctr Clin Res Munster IZKF Munst, Munster, Germany
[3] Univ Maastricht, Dept Physiol, Maastricht, Netherlands
[4] Univ Hosp Munster, Inst Pharmacol & Toxicol, D-48129 Munster, Germany
[5] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
[6] Univ Montreal, Montreal, PQ, Canada
[7] Vesalius Res Ctr KU Leuven, Vesalius Res Center VIB, Leuven, Belgium
基金
加拿大健康研究院;
关键词
Antiarrhythmic drugs; Atrial remodeling; Electrophysiology; Genetic models; Nav1.5; LONG-QT SYNDROME; TORSADES-DE-POINTES; CONDUCTION DISEASE; BRUGADA-SYNDROME; FIBRILLATION; ARRHYTHMIAS; HEART; SCN5A; MICE; REPOLARIZATION;
D O I
10.1016/j.hrthm.2010.08.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Patients with long QT syndrome (LQTS) are at increased risk not only for ventricular arrhythmias but also for atrial pathology including atrial fibrillation (AF). Some patients with "lone" AF carry Na+-channel mutations. OBJECTIVE The purpose of this study was to determine the mechanisms underlying atrial pathology in LQTS. METHODS In mice with a heterozygous knock-in long QT syndrome type 3 (LQT3) mutant of the cardiac Na+ channel (Delta KPQ-SCN5A) and wild-type (WT) littermates, atrial size, function, and electrophysiologic parameters were measured in intact Langendorff-perfused hearts, and histologic analysis was performed. RESULTS Atrial action potential duration, effective refractory period, cycle length, and PQ interval were prolonged in Delta KPQ-SCN5A hearts (all P < .05). Flecainide (1 mu M) reversed atrial action potential duration prolongation and induced postrepolarization refractoriness (P < .05). Arrhythmias were infrequent during regular rapid atrial rate in both WT and Delta KPQ-SCN5A but were inducible in 15 (38%) of 40 Delta KPQ-SCN5A and 8 (29%) of 28 WT mice upon extrastimulation. Pacing protocols generating rapid alterations in rate provoked atrial extrasystoles and arrhythmias in 6 66%) of 9 Delta KPQ-SCN5A but in 0 (0%) of 6 WT mice (P < .05). Atrial diameter was increased by nearly 10% in Delta KPQ-SCN5A mice > 5 months old without increase in fibrotic tissue. CONCLUSION Murine hearts bearing an LQT3 mutation show abnormalities in atrial electrophysiology and subtle changes in atrial dimension, including an atrial arrhythmogenic phenotype on provocation. These results support clinical data suggesting that LQTS mutations can cause atrial pathology and arrhythmogenesis and indicate that murine sodium channel LQTS models may be useful for exploring underlying mechanisms.
引用
收藏
页码:1862 / 1869
页数:8
相关论文
共 37 条
[1]   A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation [J].
Benito, Begona ;
Brugada, Ramon ;
Maria Perich, Rosa ;
Lizotte, Eric ;
Cinca, Juan ;
Mont, Lluis ;
Berruezo, Antonio ;
Maria Tolosana, Jose ;
Freixa, Xavier ;
Brugada, Pedro ;
Brugada, Josep .
HEART RHYTHM, 2008, 5 (10) :1434-1440
[2]   A common polymorphism in SCN5A is associated with lone atrial fibrillation [J].
Chen, L. Y. ;
Ballew, J. D. ;
Herron, K. J. ;
Rodeheffer, R. J. ;
Olson, T. M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) :35-41
[3]   Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation [J].
Darbar, Dawood ;
Kannankeril, Prince J. ;
Donahue, Brian S. ;
Kucera, Gayle ;
Stubblefield, Tanya ;
Haines, Jonathan L. ;
George, Alfred L., Jr. ;
Roden, Dan M. .
CIRCULATION, 2008, 117 (15) :1927-1935
[4]   Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome [J].
Darbar, Dawood ;
Kimbrough, John ;
Jawaid, Asif ;
McCray, Robert ;
Ritchie, Marylyn D. ;
Roden, Dan M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (08) :836-842
[5]   Atrial arrhythmogenesis in wild-type and Scn5a+/Δ murine hearts modelling LQT3 syndrome [J].
Dautova, Yana ;
Zhang, Yanmin ;
Sabir, Ian ;
Grace, Andrew A. ;
Huang, Christopher L. -H. .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2009, 458 (03) :443-457
[6]   Multiple mechanisms of Na+ channel-linked long-QT syndrome [J].
Dumaine, R ;
Wang, Q ;
Keating, MT ;
Hartmann, HA ;
Schwartz, PJ ;
Brown, AM ;
Kirsch, GE .
CIRCULATION RESEARCH, 1996, 78 (05) :916-924
[7]   Cardiac sodium channel mutation in atrial fibrillation [J].
Effinor, Patrick T. ;
Nam, Edwin G. ;
Shea, Marisa A. ;
Milan, David J. ;
Ruskin, Jeremy N. ;
MacRae, Caturn A. .
HEART RHYTHM, 2008, 5 (01) :99-105
[8]   Suppression of atrial fibrillation with mexiletine pharmacotherapy in a young woman with type I long QT syndrome [J].
El Yaman, Malek ;
Perry, James ;
Makielski, Jonathan C. ;
Ackerman, Michaet J. .
HEART RHYTHM, 2008, 5 (03) :472-474
[9]   Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A3 adenosine receptors [J].
Fabritz, L ;
Kirchhof, P ;
Fortmüller, L ;
Auchampach, JA ;
Baba, HA ;
Breithardt, G ;
Neumann, J ;
Boknik, P ;
Schmitz, W .
CARDIOVASCULAR RESEARCH, 2004, 62 (03) :500-508
[10]   Effect of pacing and arrhythmias mexiletine on dispersion of repolarisation and in ΔKPQ SCN5A (long QT3) mice [J].
Fabritz, L ;
Kirchhof, P ;
Franz, MR ;
Nuyens, D ;
Rossenbacker, T ;
Ottenhof, A ;
Haverkamp, W ;
Breithardt, G ;
Carmeliet, E ;
Carmeliet, P .
CARDIOVASCULAR RESEARCH, 2003, 57 (04) :1085-1093